메뉴 건너뛰기




Volumn 162, Issue 8, 2002, Pages 936-942

Gastric and duodenal safety of daily alendronate

(17)  Donahue, James G a   Chan, K Arnold a,b   Andrade, Susan E c   Beck, Arne d   Boles, Myde d   Buist, Diana S M e   Carey, Vincent J a   Chandler, Julie M f   Chase, Gary A g   Ettinger, Bruce d   Fishman, Paul e   Goodman, Michael h   Guess, Harry A f   Gurwitz, Jerry H c   LaCroix, Andrea Z e   Levin, T R d,i   Platt, Richard j  


Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; CORTICOSTEROID; NONSTEROID ANTIINFLAMMATORY AGENT;

EID: 0037156445     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.162.8.936     Document Type: Article
Times cited : (43)

References (35)
  • 3
    • 0032896590 scopus 로고    scopus 로고
    • Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: Results of the FOSIT study
    • (1999) Osteoporosis Int , vol.9 , pp. 461-468
    • Pols, H.A.1    Felsenberg, D.2    Hanley, D.A.3
  • 5
    • 0032583492 scopus 로고    scopus 로고
    • Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: Results from the Fracture Intervention Trial
    • (1998) JAMA , vol.280 , pp. 2077-2082
    • Cummings, S.R.1    Black, D.M.2    Thompson, D.E.3
  • 22
    • 0001665813 scopus 로고
    • Model robust confidence intervals using maximum likelihood estimators
    • (1986) Int Stat Rev , vol.54 , pp. 221-226
    • Royall, R.M.1
  • 34
    • 0030883544 scopus 로고    scopus 로고
    • Epidemiology and predictors of fractures associated with osteoporosis
    • (1997) Am J Med , vol.103
    • Lips, P.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.